He succeeds Eva Boratto, who is leaving the company after 11 years.
WOONSOCKET, R.I. — CVS Health announced on Tuesday that it has appointed Shawn Guertin as executive vice president and chief financial officer, effective May 28. Guertin succeeds Eva Boratto, who is leaving the company after a successful 11-year career.
“Shawn is an extraordinary leader with a proven track record of developing financial strategies to help companies drive transformation,” said CVS Health president and CEO Karen Lynch. “His deep and broad health care experience will be invaluable and I’m confident he will play an integral role as we transform CVS Health to become an even bigger part of consumers’ everyday health.”
Guertin spent eight years at Aetna where he was executive vice president, chief financial officer and chief enterprise risk officer. He was the architect of the company’s finance strategy during a period of rapid growth and transformation. He helped Aetna enter new markets and grow through expansion and acquisitions and was a key leader in shaping and affecting the merger with CVS Health in 2018. During his time in the role he was consistently recognized by Institutional Investor magazine as a top CFO.
“Since I joined the company in 2010, CVS Health has undergone a period of significant growth and change,” said Eva Boratto. “I am proud of our team and what we achieved. I am confident in CVS Health’s outlook for growth and long-term value going forward and am committed to helping the company through a seamless transition.”
Lynch added, “Eva served as CFO during a critical time following the Aetna acquisition and did an outstanding job supporting the integration of the two companies, managing our balance sheet, and helping us lead during the pandemic. Eva also drove our supplier diversity efforts, garnering external recognition of our leadership. We appreciate her achievements and dedication, and we wish Eva continued success.”
Guertin will report to Lynch and become a member of the company’s executive team. Guertin will be responsible for all aspects of the company’s financial strategy and operations, including accounting and financial reporting, investor relations, mergers and acquisitions, treasury and capital planning, investments, risk management, tax, budgeting and planning, and procurement.
“This is an exciting time for CVS Health,” said Guertin. “No other company has both the strong business and the customer reach and relationships to transform health care at scale. The pandemic has changed how Americans want to receive care and I’m excited to help CVS Health lead in a rapidly evolving marketplace.”
Most recently, Guertin served on the board of two public companies in health care and technology. He is an active supporter of Memorial Sloan Kettering and other charitable causes. Earlier in his career, Guertin was chief actuary and chief financial officer at Coventry Health Care, a leading health plan acquired by Aetna in 2012. He also served in a number of leadership positions at UnitedHealthcare and The Travelers.
CVS Health is reaffirming its 2021 guidance, which was previously provided on May 4, 2021. This includes its full year 2021 Adjusted EPS guidance range of $7.56 to $7.68 and full year 2021 cash flow from operations guidance range of $12.0 billion to $12.5 billion. CVS Health remains on track to achieve its low 3x leverage ratio goal in 2022.
As previously announced, CVS Health will hold its Investor Day on December 9, 2021.